IL6 and COVID-19: In another study, an impaired type I IFN response was detected in severe and critical COVID-19 patients, accompanied by high blood viral load and an excessive nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)–driven inflammatory response characterized by increased TNF-α and IL-6.